Cellectar Biosciences (CLRB) Operating Leases (2019 - 2026)
Cellectar Biosciences' Operating Leases came in at $1.53 million for Q2 2026, up 323.1% from $361,487 a year earlier.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Cellectar Biosciences' Operating Leases was $309,397, down 24.5% from FY2024.
- Operating Leases has declined in each of the last three years, though with a five-year compound annual growth rate of 0.5% (FY2020 to FY2025).
- Going back by year, Operating Leases was $409,586 in FY2024 (-17.1%), $494,003 in FY2023 (-10.7%), $552,981 in FY2022 (+232.5%) and $166,292 in FY2021 (-44.9%).
- The Q2 2026 figure represents the highest quarterly Operating Leases in data going back to Q1 2019.
- Year-over-year, Operating Leases increased in 1 of the last seven quarters, with growth averaging 29.2%.
- The fastest year-over-year change in Operating Leases over five years came in Q3 2023 (growth of 853.6%), and the weakest in Q3 2022 (a decline of 73.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn |
| 10 | Cellectar Biosciences | 15.47 Mn | -55.31 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.53 Mn |
| Dec 31, 2025 | 309,397.00 |
| Sep 30, 2025 | 335,895.00 |
| Jun 30, 2025 | 361,487.00 |
| Mar 31, 2025 | 386,203.00 |
| Dec 31, 2024 | 409,586.00 |
| Sep 30, 2024 | 431,929.00 |
| Jun 30, 2024 | 453,508.00 |
| Mar 31, 2024 | 474,349.00 |
| Dec 31, 2023 | 494,003.00 |
| Sep 30, 2023 | 512,750.00 |
| Jun 30, 2023 | 530,856.00 |
| Mar 31, 2023 | 548,344.00 |
| Dec 31, 2022 | 552,981.00 |
| Sep 30, 2022 | 53,769.00 |
| Jun 30, 2022 | 92,214.00 |
| Mar 31, 2022 | 129,714.00 |
| Dec 31, 2021 | 166,292.00 |
| Sep 30, 2021 | 201,970.00 |
| Jun 30, 2021 | 236,058.00 |
API Access
Cellectar Biosciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();